⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5149348 | 0.98 | MAPT (0.36) | — | |
| Benzoic Acid SCHEMBL5149506 | 0.83 | ADH5 (0.43) | — | |
| SCHEMBL5202776 | 0.80 | — | — | |
| SCHEMBL5148133 | 0.80 | TSHR (0.44) | — | |
| SCHEMBL972555 | 0.78 | — | — | |
| SCHEMBL13589000 | 0.78 | — | — | |
| SCHEMBL9285625 | 0.78 | — | — | |
| SCHEMBL11398624 | 0.78 | MAPT (0.37) | — | |
| SCHEMBL22019922 | 0.78 | — | — | |
| SCHEMBL13262611 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118355018-A | Process for the preparation of temozolomide | 克里斯泰利亚化学药物产品有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-113801079-B | Synthetic method of dinotefuran metabolite UF | 上海安谱实验科技股份有限公司 | 2024-01-09 | — | — | CN | claimed |
| CN-110177792-B | Process for preparing temozolomide and intermediates | 克里斯泰利亚化学药物产品有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-113801079-A | Synthetic method of dinotefuran metabolite UF | 上海安谱实验科技股份有限公司 | 2021-12-17 | — | — | CN | claimed |
| US-10865209-B2 | Process for preparing temozolomide and an intermediary | CRISTÁLIA PRODUTOS QUÍMICOS FARMACÊUTICOS LTDA (BR) | 2020-12-15 | — | — | US | claimed |
| US-20200190088-A1 | PROCESS FOR PREPARING TEMOZOLOMIDE AND AN INTERMEDIARY | CRISTÁLIA PRODUTOS QUÍMICOS FARMACÊUTICOS LTDA (BR) | 2020-06-18 | — | — | US | claimed |
| EP-3559001-A1 | PROCESS FOR PREPARING TEMOZOLOMIDE AND AN INTERMEDIARY | Cristália Produtos Químicos Farmacêuticos LTDA (BR) | 2019-10-30 | — | — | EP | claimed |
| WO-2018112589-A1 | PROCESS FOR PREPARING TEMOZOLOMIDE AND AN INTERMEDIARY | CRISTÁLIA PRODUTOS QUÍMICOS FARMACÊUTICOS LTDA (BR) | 2018-06-28 | — | — | WO | claimed |
| EP-1539707-A4 | METHOD AND COMPOUNDS FOR PROMOTING HEALING AND REDUCING INFLAMMATION | BIODIEM LTD (AU) | 2007-05-30 | — | — | EP | claimed |
| EP-1539707-A1 | METHOD AND COMPOUNDS FOR PROMOTING HEALING AND REDUCING INFLAMMATION | Biodiem Ltd. (AU) | 2005-06-15 | — | — | EP | claimed |
| WO-2004013108-A1 | METHOD AND COMPOUNDS FOR PROMOTING HEALING AND REDUCING INFLAMMATION | BIODIEM LIMITED (AU) | 2004-02-12 | — | — | WO | claimed |
| EP-4747260-A1 | MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. Hoffmann-La Roche AG (CH) | 2026-05-27 | — | — | EP | disclosed |
| US-20260138951-A1 | TREATING PKU WITH SPIRO-SUBSTITUTED AND OTHER PIPERIDINE INHIBITORS OF SLC6A19 FUNCTION | JNANA THERAPEUTICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| WO-2026090317-A1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| EP-4727537-A2 | SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF | Adaxion Therapeutics, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20060135587-A1 | Method and compounds for promoting healing and reducing inflammation | BIODIEM, LTD. (AU) | 2006-06-22 | — | — | US | disclosed |
| EP-1539707-A1 | METHOD AND COMPOUNDS FOR PROMOTING HEALING AND REDUCING INFLAMMATION | Biodiem Ltd. (AU) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004013108-A1 | METHOD AND COMPOUNDS FOR PROMOTING HEALING AND REDUCING INFLAMMATION | BIODIEM LIMITED (AU) | 2004-02-12 | — | — | WO | disclosed |
| US-4066778-A | ANTIBACTERIAL, ANTIPROTAZOA, ANTHELMINTIC | CIBA-GEIGY CORPORATION (US) | 1978-01-03 | — | — | US | disclosed |
| US-3976778-A | ANTHELMINTIC, BACTERICIDE, ANTIPROTOZOA | CIBA-GEIGY CORPORATION (US) | 1976-08-24 | — | — | US | disclosed |